Evidence map›Paper›PMID 39264174›Full record

ArticleNeurosurgery2025

Understanding the Importance of Blood-Brain Barrier Alterations in Brain Arteriovenous Malformations and Implications for Treatment: A Dynamic Contrast-Enhanced-MRI-Based Prospective Study.

Alejandra Mosteiro, Leire Pedrosa, Sergio Amaro, Sebastián Menéndez-Girón, Luis Reyes, Nicolás de Riva, Maite Misis, Jordi Blasco, Carla Vert, Carlos J Dominguez and 4 more

Abstract read
In one paragraph

Article in Neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Mutant KRAS in brain endothelial cells promotes vascular inflammation and impairs vascular integrity in brain arteriovenous malformation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  2. Article
  3. Article
  4. Profiling Tight Junction Protein Expression in Brain Vascular Malformations.International journal of molecular sciences · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alejandra MosteiroDepartment of Neurosurgery, Hospital Clinic of Barcelona, Barcelona , Spain.
Leire PedrosaDepartment of Neurosurgery, Hospital Clinic of Barcelona, Barcelona , Spain.
Sergio AmaroInstituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona , Spain.
Sebastián Menéndez-GirónDepartment of Neurological Surgery, Germans Trias i Pujol University Hospital, Badalona , Spain.
Luis ReyesDepartment of Neurosurgery, Hospital Clinic of Barcelona, Barcelona , Spain.
Nicolás de RivaNeuroanesthesia Division, Anesthesiology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona , Spain.
Maite MisisIntensive Care Department, Germans Trias i Pujol University Hospital, Badalona , Spain.
Jordi BlascoUniversity of Barcelona, Barcelona , Spain.
Carla VertNeuroradiology Department, Germans Trias i Pujol University Hospital, Badalona , Spain.
Carlos J DominguezDepartment of Neurological Surgery, Germans Trias i Pujol University Hospital, Badalona , Spain.
Joaquim EnseñatDepartment of Neurosurgery, Hospital Clinic of Barcelona, Barcelona , Spain.
Abraham MartínAchucarro Basque Center for Neuroscience, Bizkaia , Spain.
Ana Rodriguez-HernándezDepartment of Neurological Surgery, Germans Trias i Pujol University Hospital, Badalona , Spain.
Ramon TornéDepartment of Neurosurgery, Hospital Clinic of Barcelona, Barcelona , Spain.ORCID 0000-0001-7932-2528

Funding

Fundacià la Maratà de TV3
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe major clinical implication of brain arteriovenous malformations (bAVMs) is spontaneous intracranial hemorrhage. There is a growing body of experimental evidence proving that inflammation and blood-brain barrier (BBB) dysfunction are involved in both the clinical course of the disease and the risk of bleeding. However, how bAVM treatment affects perilesional BBB disturbances is yet unclear.

methodsWe assessed the permeability changes of the BBB using dynamic contrast-enhanced MRI (DCE-MRI) in a series of bAVMs (n = 35), before and at a mean of 5 (±2) days after treatment. A set of cerebral cavernous malformations (CCMs) (n = 16) was used as a control group for the assessment of the surgical-related collateral changes. The extended Tofts pharmacokinetic model was used to extract permeability (K trans ) values in the lesional, perilesional, and normal brain tissues.

resultsIn patients with bAVM, the permeability of BBB was higher in the perilesional of bAVM tissue compared with the rest of the brain parenchyma (mean K trans 0.145 ± 0.104 vs 0.084 ± 0.035, P = .004). Meanwhile, no significant changes were seen in the perilesional brain of CCM cases (mean K trans 0.055 ± 0.056 vs 0.061 ± 0.026, P = .96). A significant decrease in BBB permeability was evident in the perilesional area of bAVM after surgical resection (mean K trans 0.145 ± 0.104 vs 0.096 ± 0.059, P = .037). This benefit in BBB permeability reduction after surgery seemed to surpass the relative increase in permeability inherent to the surgical manipulation.

conclusionIn contrast to CCMs, BBB permeability in patients with bAVM is increased in the perilesional parenchyma, as assessed using DCE-MRI. However, bAVM surgical resection seems to reduce BBB permeability in the perilesional tissue. No evidence of the so-called breakthrough phenomenon was detected in our series. DCE-MRI could become a valuable tool to follow the longitudinal course of BBB damage throughout the natural history and clinical course of bAVMs.

Indexed as

Blood-Brain BarrierIntracranial Arteriovenous MalformationsMagnetic Resonance ImagingAdolescentAdultAgedCapillary PermeabilityContrast MediaFemaleHumansMaleMiddle AgedProspective StudiesYoung AdultContrast Media

Identifiers

PMID39264174
PMCPMC11882286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.